[1] |
Yue X,Wang P,Xu J,et al.MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A[J]. Oncol Rep,2012,27(4):1200-6.
|
[2] |
Majid S,Saini S,Dar AA,et al.MicroRNA-205 inhibits Srcmediated oncogenic pathways in renal cancer[J].Cancer Res,2011,71(7):2611-21.
|
[3] |
Matsushima K,Isomoto H,Yamaguchi N,et al.MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells[J].J Transl Med,2011,9:30.
|
[4] |
Lebastchi AH,Kunstman JW,Carling T.Adrenocortical carcinoma: current therapeutic state-of-the-art[J].J Oncol,2012,2012:234726.
|
[5] |
Soon PS,Libe R,Benn DE,et al.Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors[J].Ann Surg,2008,247(1): 15 7-64.
|
[6] |
Wu YG,Xiao G,Xu WQ,et al.Construction and identification of eukaryotic expression vector of human miR-205[J].Shandong Yi Yao,2012,52(44):20-2,cover 2.[吴义高,肖戈,徐文清,等.人 miR-205真核表达载体的构建及鉴定[J].山东医药. 2012,52(44): 20 -2,封2].
|
[7] |
Allolio B,Hahner S,Weismann D,et al.Management of adrenocortical carcinoma[J].Clin Endocrinol (Oxf),2004,60(3): 27 3-87.
|
[8] |
Shen W,Hu WL.Cellular senescence and adrenal tumors[J].Shi Yong Yi Xue Za Zhi,2006,22(23):2819-20.[沈文,胡卫列.细胞衰 老与肾上腺肿瘤[J].实用医学杂志,2006,22(23):2819-20.]
|
[9] |
Brewer CA,Blessing JA,Nagourney RA,et al.Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase Ⅱ study of the Gynecologic Oncology Group[J]. Gynecol Oncol,2006,100(2):385-8.
|
[10] |
Mattie MD,Benz CC,Bowers J,et al.Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies[J].Mol Cancer,2006,5:24.
|
[11] |
Obernosterer G,Leuschner PJ,Alenius M,et al.Post-transcriptional regulation of microRNA expression[J].RNA,2006,12(7):1161-7.
|
[12] |
Qin AY,Zhang XW,Liu L,et al.MiR-205 in cancer: an angel or a devil?[J].Eur J Cell Biol,2013,92(2):54-60.
|
[13] |
Qin G,Kishore R,Dolan CM,et al.Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF[J].Proc Natl Acad Sci U S A,2006,103(29):11015-20.
|
[14] |
Zhu Y,Jin K,Mao XO,et al.Vascular endothelial growth factor promotes proliferation of cortical neuron precursors by regulating E2F expression[J].FASEB J,2003,17(2):186-93.
|
[15] |
Merdzhanova G,Gout S,Keramidas M,et al.The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus ountiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo[J].Oncogene,2010, 29 (39):5392-403.
|